Jorge Alberto Ocantos MD, Presenter: Nothing to Disclose

Nestor Hugo Kisilevzky, Abstract Co-Author: Nothing to Disclose

Julio Ramon Coronil MD, Abstract Co-Author: Nothing to Disclose

Andres Kohan MD, Abstract Co-Author: Fellowship funded, Koninklijke Philips NV

Ignacio Ardanaz, Abstract Co-Author: Nothing to Disclose

Pablo Francisco Martinez, Abstract Co-Author: Nothing to Disclose

Oscar Peralta, Abstract Co-Author: Nothing to Disclose

Oscar Hector Damia, Abstract Co-Author: Nothing to Disclose

Ricardo D. Garcia-Monaco MD, PhD, Abstract Co-Author: Research Consultant, Siemens AG Research Consultant, BTG International Ltd

To describe prostate normal anatomy, pathophysiology, changes of the gland observed in BPH, clinical manifestations, and treatment options for benign prostatic hyperplasia (BPH). To review technique, indications, contraindications and potential complications of prostatic arterial embolization (PAE). To describe prostatic MR imaging technique. To review MR findings before and after embolizatión (prostate volume determination, tissue characteristics, isquemic changes and relation central and periferical gland)

MR Prostate anatomy: Normal and changes in benign prostatic hyperplasia. BPH: Pathophysiology and clinical manifestations. BPH: Treatment options and review of prostatic arterial embolization in particular. MR Protocol and technique. MR findings before and after PAE in benign prostatic hyperplasia. Conclusion and future perspective of MR Imaging before and after PAE.

http://abstract.rsna.org/uploads/2014/14002525/14002525_vsyc.pdf

Ocantos, J, Kisilevzky, N, Coronil, J, Kohan, A, Ardanaz, I, Martinez, P, Peralta, O, Damia, O, Garcia-Monaco, R, MR Imaging before and after Transcatheter Embolizatión in Benign Prostatic Hyperplasia: What the Radiologist Needs to Know.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002525.html